Pediatric leukemia ‘super drug’ could be developed in the coming years

Jan 14, 2019 | Impact, News

Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, according to three studies published over the last two years in the journal Cell, and the final paper published Dec. 20 in Genes &...

Where cancer lurks

Nov 1, 2018 | Gallery, Impact, News

Vadim Backman, CLP resident member and Walter Dill Scott Professor of Biomedical Engineering, is featured on the Fall 2018  cover of Northwestern magazine. The story explains Backman’s path-breaking work in chromatin regulation to fight resistance in cancer and...

Cheek swab may help diagnose precancers, early malignancies

Aug 9, 2018 | Gallery, Impact, News, Slideshow

Original article published on July 11, 2018 in Helio, HemOncToday by Rob Volansky Promising results for a simple cheek swab test to detect precancerous lesions in lung cancer may signify an era of affordable first-line diagnostic procedures, according to researchers...

Understanding the full puzzle of proteins: A chemistry pioneer works to improve a flawed test for a common cancer

Jul 30, 2018 | Impact, News, September Newsletter

DNA sequencing used to cost thousands of dollars. Now, you can pay $99 for a genetic screening, all without leaving your house. “The genome was a wild frontier in the 90s, but ten years later, it wasn’t,” says molecular biosciences professor and Chemistry of Life...

Unlocking Cures to Orphan Diseases

Jan 1, 2017 | Impact

Professor Richard Silverman (Chemistry and Molecular Biology) is not content to rest on his laurels following his extraordinary discovery of pregabalin (Lyrica®). Instead, he has used the translational resources of the Chemistry of Life Processes Institute to develop...

Early Detection Saves Eyes

Jan 1, 2017 | Impact

Nearly 40 million Americans are at risk for vision loss or blindness due to diabetes and age-related macular degeneration. Often, these diseases are diagnosed and treated much too late, after irreversible vision loss has started to occur. Hao F. Zhang (Biomedical...